Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease diabetes mellitus, insulin-dependent
Symptom C0011884|diabetic retinopathy
Sentences 12
PubMedID- 21868777 Decline in the cumulative incidence of severe diabetic retinopathy in patients with type 1 diabetes.
PubMedID- 25866794 One study found that latanoprost (a pgf2α agonist) used topically significantly reduced dilation of retinal arterioles in type i diabetes patients with diabetic retinopathy, whereas topical diclofenac had no significant effect .
PubMedID- 22966098 A population-based study of the risk of diabetic retinopathy in patients with type 1 diabetes and celiac disease.
PubMedID- 26181138 Conclusions and relevance: our findings do not provide evidence for a relationship between increasing levels of serum oxidized low-density lipoprotein and the incidence of macular edema or the worsening of diabetic retinopathy in persons with type 1 diabetes.
PubMedID- 23642967 Racial disparities in screening for diabetic retinopathy in youth with type 1 diabetes.
PubMedID- 20536515 Pregnancy-induced sight-threatening diabetic retinopathy in women with type 1 diabetes.
PubMedID- 21088442 Variants of the adenosine a(2a) receptor gene are protective against proliferative diabetic retinopathy in patients with type 1 diabetes.
PubMedID- 24864506 diabetic retinopathy in patients with type 1 diabetes mellitus.
PubMedID- 24101700 Incidence of stroke according to presence of diabetic nephropathy and severe diabetic retinopathy in patients with type 1 diabetes.
PubMedID- 26200806 Elevated levels of intermediate cd14(bright) cd16(+) and non-classical cd14(dim) cd16(+) monocytes predict development of diabetic retinopathy in patients with type 1 diabetes.
PubMedID- 21896933 In this article, we present suggestive evidence that an exonic snp rs17353856 in the suv39h2 is associated with diabetic retinopathy in patients with type 1 diabetes.
PubMedID- 25204977 Effect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the dcct/edic.

Page: 1